Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
QXQ | Ann: Appendix 3B | 11/02/15 | 12 | 7.9K | |||
|
|||||||
QXQ | Ann: Becoming a substantial holder | 16/01/15 | 0 | 816 | |||
|
|||||||
QXQ | Ann: Initial Director's Interest Notice | 16/01/15 | 0 | 733 | |||
|
|||||||
QXQ | Ann: Initial Director's Interest Notice | 16/01/15 | 0 | 788 | |||
|
|||||||
QXQ | Ann: Initial Director's Interest Notice | 16/01/15 | 0 | 687 | |||
|
|||||||
QXQ | Ann: Final Director's Interest Notice | 13/01/15 | 0 | 670 | |||
|
|||||||
QXQ | Ann: Final Director's Interest Notice | 13/01/15 | 0 | 553 | |||
|
|||||||
QXQ | Ann: Change of Director's Interest Notice | 13/01/15 | 0 | 633 | |||
|
See All Discussions